Pura Vida Investments’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Pura Vida Investments’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-71,320	Closed	-$1.55M	–	317
2021 Q4	$1.55M	Sell	71,320 -2,313	-3%	-$51K	0.06%	157
2021 Q3	$1.61M	Sell	73,633 -1,334	-2%	-$26.7K	0.05%	199
2021 Q2	$1.46M	Sell	74,967 -2,296	-3%	-$41.7K	0.05%	168
2021 Q1	$1.33M	Buy	77,263 +58,323	+308%	+$924K	0.04%	184
2020 Q4	$304K	Hold	18,940	–	–	0.01%	173
2020 Q3	$202K	Hold	18,940	–	–	0.01%	148
2020 Q2	$229K	Hold	18,940	–	–	0.02%	117
2020 Q1	$186K	Buy	+18,940	New	+$248K	0.02%	91

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Pura Vida Investments's SRRA Position: Q1 2022 in Review

Pura Vida Investments sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q1 2022, closing a stake of 71,320 shares — an estimated $1.55M sold.

Pura Vida Investments first reported a position in SRRA in Q1 2020 and held it in 8 quarters. The position peaked at $1.61M in Q3 2021. 75 funds tracked by Wall St. Rank hold SRRA as of Q1 2022.

Pura Vida Investments reported no remaining Sierra Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Pura Vida Investments sold 71,320 Sierra Oncology, Inc. Common Stock shares in Q1 2022, an estimated $1.55M.
Pura Vida Investments first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2020 and held it in 8 quarters.
Pura Vida Investments's Sierra Oncology, Inc. Common Stock position peaked at $1.61M in Q3 2021.
75 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q1 2022.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.